Journal of nursing care quality · 2025
Safety and Cost Evaluation of Modified Medium-Length Catheters in Patients With Advanced Cancer: A Randomized Controlled Trial.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yu Yanfen, Zhou Qin, Ye Guanjun, Yan Jieqiong, Chen Yunjie, Wang Bona
Аннотация
BACKGROUND: Deep vein catheterization is common in patients with advanced cancer, but safety and cost comparisons between catheter types are limited.
PURPOSE: To evaluate the safety and economic impact of a modified medium-length catheter versus a standard peripherally inserted central catheter (PICC) line in patients with advanced cancer.
METHODS: A prospective cohort study was conducted involving 160 patients with advanced cancer receiving palliative care between January 2022 and April 2024. Patients were randomized to a study group (modified medium-length catheter) or control group (PICC line). Venous complications, satisfaction, and costs were compared.
RESULTS: The study group had lower rates of venous thrombosis, bleeding, and catheter infection. Patient satisfaction and costs were also significantly better in the study group.
CONCLUSIONS: The modified medium-length catheter provides better safety, higher satisfaction, and reduced costs, making it a preferred option for patients with advanced cancer.
PURPOSE: To evaluate the safety and economic impact of a modified medium-length catheter versus a standard peripherally inserted central catheter (PICC) line in patients with advanced cancer.
METHODS: A prospective cohort study was conducted involving 160 patients with advanced cancer receiving palliative care between January 2022 and April 2024. Patients were randomized to a study group (modified medium-length catheter) or control group (PICC line). Venous complications, satisfaction, and costs were compared.
RESULTS: The study group had lower rates of venous thrombosis, bleeding, and catheter infection. Patient satisfaction and costs were also significantly better in the study group.
CONCLUSIONS: The modified medium-length catheter provides better safety, higher satisfaction, and reduced costs, making it a preferred option for patients with advanced cancer.